Our other prescription drug problem. | AHRQ Patient Safety Network

Our other prescription drug problem. | AHRQ Patient Safety Network

• Commentary
 
• Published February 2018

Our other prescription drug problem.

Lembke A, Papac J, Humphreys K. N Engl J Med. 2018;378:693-695.

Unintended consequences can emerge when targeted strategies divert attention from concurrent safety concerns. This editorial recommends that lessons learned during efforts to improve opioid prescribing should be employed to reduce the potential for overprescription and misuse of benzodiazepines.

PubMed citationFree full textRelated news article

Related Resources

JOURNAL ARTICLE › STUDY

Safer prescribing—a trial of education, informatics, and financial incentives.

Dreischulte T, Donnan P, Grant A, Hapca A, McCowan C, Guthrie B. N Engl J Med. 2016;374:1053-1064.

JOURNAL ARTICLE › STUDY

Adherence to black box warnings for prescription medications in outpatients.

Lasser KE, Seger DL, Yu DT, et al. Arch Intern Med. 2006;166:338-344.

TOOLS/TOOLKIT › TOOLKIT

Opioid Wisely.

Choosing Wisely Canada.

NEWSPAPER/MAGAZINE ARTICLE

Ten ERs in Colorado tried to curtail opioids and did better than expected.

Daley J. Colorado Public Radio. February 23, 2018.

JOURNAL ARTICLE › STUDY

Communication failure: analysis of prescribers' use of an internal free-text field on electronic prescriptions.

Ai A, Wong A, Amato M, Wright A. J Am Med Inform Assoc. 2018 Feb 21; [Epub ahead of print].

View More